Using gene arrays in diagnosis of rejection

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 34-39

  Khatri, Purvesh ^a,b   Sarwal, Minnie M ^a,b  

^a Division of Nephrology   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Microarray; Transplant

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; CD8 ANTIGEN; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; FAS LIGAND; GAMMA INTERFERON; MATRILYSIN; PROTEIN TRIB1; UNCLASSIFIED DRUG;

ANGIOGENESIS; CHRONIC GRAFT REJECTION; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS; GLOBIN GENE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; WOUND HEALING; ALLOTRANSPLANTATION; ANIMAL; CHRONIC DISEASE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETIC MARKER; GENETIC SCREENING; GENETICS; METHODOLOGY; PREDICTION AND FORECASTING; REPRODUCIBILITY; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

ANIMALS; CHRONIC DISEASE; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC SCREENING; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS; TREATMENT OUTCOME;

EID: 67649233063     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32831e13d0     Document Type: Review

References (51)

1. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3:708. (Pubitemid 36745243)
2. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7:518. (Pubitemid 46376465)
3. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467.
4. Weintraub LA, Sarwal MM. Microarrays: a monitoring tool for transplant patients? Transl Int 2006; 19:775.
5. Jun AS, Liu SH, Koo EH, et al. Microarray analysis of gene expression in human donor corneas. Arch Ophthalmol 2001; 119:1629.
6. Akalin E, Hendrix RC, Polavarapu RG, et al. Gene expression analysis in human renal allograft biopsy samples using high-density oligoarray technology. Transplantation 2001; 72:948. (Pubitemid 32879872)
7. Flechner SM, Kurian SM, Head SR, et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004; 4:1475.
8. Fujino M, Kitazawa Y, Kawasaki M, et al. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transpl 2004; 10:379. (Pubitemid 38380312)
9. Inkinen K, Lahesmaa R, Brandt A, et al. DNA microarray-based gene expression profiles of cytomegalovirus infection and acute rejection in liver transplants. Transplant Proc 2005; 37:1227. (Pubitemid 40590844)
10. Lu BS, Yu AD, Zhu X, et al. Sequential gene expression profiling in lung transplant recipients with chronic rejection. Chest 2006; 130:847. (Pubitemid 44423619)
11. Sarwal M, Chua M-S, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349:125. (Pubitemid 36818782)
12. Scherer A, Krause A, Walker JR, et al. Optimized protocol for linear RNA amplification and application to gene expression profiling of human renal biopsies. Biotechniques 2003; 34:546. (Pubitemid 36298179)
13. Sotiriou C, Khanna C, Jazaeri AA, et al. Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. J Mol Diagn 2002; 4:30. (Pubitemid 44698433)
14. Xu B, Sakkas LI, Slachta CA, et al. Apoptosis in chronic rejection of human cardiac allografts. Transplantation 2001; 71:1137.
15. Brouard S, Mansfield E, Braud C, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007; 104:15448. (Pubitemid 47502937)
16. Kawasaki M, Iwasaki M, Koshiba T, et al. Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients. Int Surg 2007; 92:276.
17. Lande JD, Patil J, Li N, et al. Novel insights into lung transplant rejection by microarray analysis. Proc Am Thorac Soc 2007; 4:44. (Pubitemid 46067562)
18. Martinez-Llordella M, Puig-Pey I, Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7:309. (Pubitemid 46096324)
19. Mas V, Maluf D, Archer K, et al. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation 2007; 83:448. (Pubitemid 46667849)
20. Schena FP, Cerullo G, Torres DD, et al. Searching for IgA nephropathy candidate genes: genetic studies combined with high throughput innovative investigations. Contrib Nephrol 2007; 157:80.
21. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7:2712. This article proposes analysis of microarray gene expression in organ transplant by first grouping the genes based on different biological processes or pathways they are involved in. Building a classifier or a predictor based on such a group of genes is shown to correlate well with histopathological diagnosis.
22. Vitalone MJ, O'Connell PJ, Jimenez-Vera E, et al. Epithelial-to- mesenchymal transition in early transplant tubulointerstitial damage. J Am Soc Nephrol 2008; 19:1571.
23. Allanach K, Mengel M, Einecke G, et al. Comparing microarray versus RTPCR assessment of renal allograft biopsies: similar performance despite different dynamic ranges. Am J Transplant 2008; 8:1006.
24. Ashton-Chess J, Giral M, Mengel M, et al. Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008; 19:1116. This article identified a novel biomarker in PBMCs for kidney and heart allografts in human as well as rat. This finding, in different organs across different organisms, suggests a common mechanism inherent to chronic AMR.
25. Maluf DG, Mas VR, Archer KJ, et al. Molecular pathways involved in loss of kidney graft function with tubular atrophy and interstitial fibrosis. Mol Med 2008; 14:276.
26. Doki T, Mello M, Mock D, et al. Intragraft gene expression profile associated with the induction of tolerance. BMC Immunol 2008; 9:5.
27. Edemir B, Kurian SM, Eisenacher M, et al. Activation of counter-regulatory mechanisms in a rat renal acute rejection model. BMC Genomics 2008; 8:71. (Pubitemid 351344692)
28. Jovanovic V, Dugast A-S, Heslan J-M, et al. Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodies. J Immunol 2008; 180:1317. This study found evidence of protection from within a tolerant graft, consistent with previous studies. Notably, this study identified role of noncanonical WNT signaling pathway for the first time in induction of tolerance in organ transplant.
29. Streblow DN, Kreklywich CN, Andoh T, et al. The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants. Am J Transplant 2008; 8:277.
30. Brands K, Colvin E, Williams LJ, et al. Reduced immunogenicity of first-trimester human fetal pancreas. Diabetes 2008; 57:627. This article provides another evidence of reduced immunogenicity of fetal tissues. It shows that the first-trimester fetal tissues are more tolerant that the second-trimester. Further investigation has potential to improve allograft tolerance.
31. Li L, Ying L, Naesens M, et al. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol Genomics 2008; 32:190. This article underlines the problems posed by dominant expression of globin genes in blood for identification of biomarkers. It also shows the inability of the current methods in globin reduction.
32. Dekel B, Burakova T, Ben-Hur H, et al. Engraftment of human kidney tissue in rat radiation chimera: II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation 1997; 64:1550.
33. Erdag G, Morgan JR. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model. Transplantation 2002; 73:519. (Pubitemid 34193609)
34. Lopes MF, Cabrita AM, Patricio JA. Fetal intestinal graft is the best source for intestinal transplantation. Pediatr Surg Int 2000; 16:364.
35. Dekel B, Burakova T, Arditti FD, et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 2003; 9:53. (Pubitemid 36098260)
36. Salama AD, Womer KL, Sayegh MH. Clinical transplantation tolerance: many rivers to cross. J Immunol 2007; 17:5419.
37. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet 2005; 365:488. (Pubitemid 40215731)
38. Sayegh MH, Carpenter CB. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004; 351:2761.
39. Pascual M, Theruvath T, Kawai T, et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346:580. (Pubitemid 34438820)
40. Donauer J, Rumberger B, Klein M, et al. Expression profiling on chronically rejected transplant kidneys. Transplantation 2003; 76:539. (Pubitemid 37013260)
41. Scherer A, Krause A, Walker JR, et al. Early prognosis of the development of renal chronic allograft rejection by gene expression profiling of human protocol biopsies. Transplantation 2003; 75:1323. (Pubitemid 36513042)
42. Chang HY, Nuyten DS, Sneddon JB, et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 2005; 102:3738.
43. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003; 95:14. (Pubitemid 36124291)
44. Colvin RB. Getting out of flatland: into the third dimension of microarrays. Am J Transplant 2007; 7:2650.
45. Chen H-Y, Yu S-L, Chen C-H, et al. A five-gene signature and clinical outcome in nonsmall-cell lung cancer. N Engl J Med 2007; 356:11.
46. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350:1828.
47. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346:1937. (Pubitemid 34651353)
48. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355:2631. (Pubitemid 44969122)
49. Draghici S, Khatri P, Eklund AC, Szallasi Z. Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 2006; 22:101. (Pubitemid 43152029)
50. Mannon RB, Kirk AD. Beyond histology: novel tools to diagnose allograft dysfunction. Clin J Am Soc Nephrol 2006; 1:358.
51. Perez-Iratxeta C, Andrade MA. Inconsistencies over time in 5% of NetAffx probe-to-gene annotations. BMC Bioinform 2005; 6:183. (Pubitemid 41372483)